|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Amortization of intangible lease asset | |||||
| Amortization of debt costs | |||||
| Loan modification expense | |||||
| Non-cash expense related to restricted stock and options granted | |||||
| Impairment expense/Allowance for receivable | |||||
| Forgiveness of accounts payable | |||||
| Depreciation | |||||
| Realized gain on marketable securities | |||||
| Unrealized gain on marketable securities | |||||
| Loss (gain) on sale of properties | |||||
| Interest expense added to debt principal | |||||
| Changes in operating assets and liabilities | |||||
| Accounts receivable | |||||
| Deferred rent receivable | |||||
| Prepaid expenses and deposits | |||||
| Other liabilities | |||||
| Accounts payable | |||||
| Tenant security deposits | |||||
| Accrued expenses | |||||
| Prepaid rent | |||||
| Net cash used in operating activities | |||||
| Investing activities | |||||
| Cash received for sale of properties | |||||
| Sale of marketable securities | |||||
| Purchase of marketable securities | |||||
| Change in value of marketable securities | |||||
| Cash paid for purchase of equipment | |||||
| Unrealized gain on marketable securities | |||||
| Cash received for mortgage loan receivables | |||||
| Net cash provided by investing activities | |||||
| Financing activities | |||||
| Proceeds received from debt | |||||
| Cash paid for offering related expenses | |||||
| Proceeds from stock issuance | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash and cash equivalents and restricted cash | |||||
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation, Beginning Balance | |||||
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation, Ending Balance | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest paid | |||||
| Reclass of deferred debt issuance costs to liability upon reduction of total loan commitment | |||||
| Dividends accrued on preferred stock | |||||
| Financed equipment purchase | |||||
| Non-cash transactions | |||||
| Land and greenhouse properties transferred in lieu of debt repayment | |||||
| Mortgage loan receivables entered into in connection with sale of properties | |||||
| Accrued interest and loan expenses transferred to loan | |||||
| Equipment written off against financing liabilities | |||||
| Offering related expenses included in accounts payable | |||||
Loading...